Janone Inc. (NASDAQ:ALTS) Short Interest Down 50.4% in December

Janone Inc. (NASDAQ:ALTS) was the recipient of a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 62,900 shares, a decline of 50.4% from the December 15th total of 126,700 shares. Based on an average daily volume of 198,900 shares, the short-interest ratio is currently 0.3 days. Currently, 0.5% of the company’s shares are sold short.

Janone Trading Down 0.7 %

ALTS opened at $6.09 on Thursday. The business’s fifty day moving average price is $3.69. Janone has a twelve month low of $0.50 and a twelve month high of $7.09. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 1.96.

About Janone

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.